# Thrombolysis in STEMI Patients Compared With pPCI on Recanalization Time in the Context of the COVID-19 Outbreak.

> **NCT05354128** · NA · UNKNOWN · sponsor: **Ya-Wei Xu** · enrollment: 120 (estimated)

## Conditions studied

- STEMI - ST Elevation Myocardial Infarction

## Interventions

- **DRUG:** Thrombolytic
- **PROCEDURE:** percutaneous coronary stenting

## Key facts

- **NCT ID:** NCT05354128
- **Lead sponsor:** Ya-Wei Xu
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-04-01
- **Primary completion:** 2022-11-30
- **Final completion:** 2023-04-30
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2022-05-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05354128

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05354128, "Thrombolysis in STEMI Patients Compared With pPCI on Recanalization Time in the Context of the COVID-19 Outbreak.". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT05354128. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*